3 ms·
It's called an orphan drug--when it's too expensive to make a profit on it, the FDA (IIRC) steps in and subsidizes it.
by hyperdimension 5y ago
It's called an orphan drug--when it's too expensive to make a profit on it, the FDA (IIRC) steps in and subsidizes it.
- lotsofpulp 5y agoI actually meant that Medicare/Medicaid/Tricare (aka US government) do not specifically reject treatment because of price. ACA also requires managed care organizations (aka health insurance companies) to cover pretty much all proven treatments. As an example, the new Hep C medications are $80k+ per dose or something if I recall correctly, and Medicaid pays for it.